ALHC — Alignment Healthcare, Inc. stock price, charts and financials

QT30Alignment Healthcare, Inc.

Alignment Healthcare, Inc. (NASDAQ: ALHC) is a Healthcare company in the Medical - Healthcare Plans industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
13.52
-1.04-7.14%
OverviewShort InterestFilings
ALHCQT30Alignment Healthcare, Inc.·NASDAQ
13.52-7.14%
News
Down 7.1% — INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC (globenewswire.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
CLOV-1.39%$4.27OSCR-1.17%$30.38MOH-1.75%$191.36CNC+0.49%$64.07HUM-3.30%$362.16CI-2.84%$274.05ELV-1.25%$378.00CVS-0.90%$104.42
Snapshot
Index-P/E76.63EPS (ttm)0.19Insider Own-Shs Outstand206.73MPerf Week-22.01%
Market Cap3.01BForward P/E33.43EPS next Y0.44Insider Trans-0.89%Shs Float187.52MPerf Month-38.82%
Enterprise Value2.32BPEG1.04EPS next Q0.06Inst Own-Short Float13.23%Perf Quarter-28.13%
Income41.00MP/S0.66EPS this Y-0.62%Inst Trans-Short Ratio4.22Perf Half Y-35.38%
Sales4.58BP/B11.36EPS next Y130.63%ROA3.18%Short Interest24.81MPerf YTD-26.28%
Book/sh1.28P/C4.34EPS next 5Y73.56%ROE20.02%52W High23.33 -42.04%Perf Year5.66%
Cash/sh3.35P/FCF14.94EPS past 3/5Y-ROIC9.23%52W Low11.99 12.78%Perf 3Y150.60%
Dividend Est.-EV/EBITDA26.70Sales past 3/5Y40.17% 32.72%Gross Margin5.44%Volatility8.23% 6.69%Perf 5Y-25.94%
Dividend TTM-EV/Sales0.51EPS Y/Y TTM128.36%Oper. Margin1.20%ATR (14)1.42Perf 10Y-
Dividend Ex-Date-Quick Ratio1.70Sales Y/Y TTM69.30%Profit Margin0.89%RSI (14)26.98Recom2.06
Dividend Gr. 3/5Y-Current Ratio1.70EPS Q/Q142.86%SMA20-26.15%Beta1.12Target Price19.00
Payout0.00%Debt/Eq1.89Sales Q/Q31.63%SMA50-24.99%Rel Volume1.80Prev Close14.56
Employees1,849LT Debt/Eq1.88EarningsOct 29SMA200-24.58%Avg Volume6.16MPrice13.52
IPO DateMar 26, 2021Option/ShortYes / YesEPS/Sales Surpr.31.75% 1.96%Net Debt/EBITDA-7.94Volume11,072,458Change-7.14%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-03-26ReiteratedRaymond JamesStrong Buy$22 → $19
May-26-26ReiteratedBarclaysEqual Weight$19 → $16
May-07-26ReiteratedRaymond JamesStrong Buy$27 → $22
May-01-26ReiteratedBarclaysEqual Weight$18 → $19
May-01-26ReiteratedUBSNeutral$21 → $22
Jan-30-26ReiteratedRobert W. Baird$22 → $28
Jan-22-26ReiteratedKeyBancOverweight$21 → $28
Jan-14-26ReiteratedUBSNeutral$18 → $21
Jan-06-26ReiteratedPiper SandlerOverweight$21 → $30
Nov-24-25UpgradeJP MorganNeutral → Overweight
Latest News
Aug-04-26
Aug-04-2605:43PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHCglobenewswire.com
03:44PM
Lowey Dannenberg, P.C. is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Violations of the Federal Securities Lawsglobenewswire.com
07:15AM
Kaplan Fox Encourages Alignment Healthcare, Inc. (ALHC) Investors to Contact the Firm Regarding a Securities Investigationnewsfilecorp.com
Aug-03-26
Aug-03-2602:50PM
Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19Benzinga
11:00AM
Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation Continuesglobenewswire.com
10:36AM
Down 37.6% in 4 Weeks, Here's Why Alignment Healthcare (ALHC) Looks Ripe for a Turnaroundzacks.com
10:00AM
Kaplan Fox Advises Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) of an Investigation into Possible Securities Law Violationsglobenewswire.com
09:00AM
Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Ongoing Securities Fraud Investigationglobenewswire.com
07:00AM
Kaplan Fox is Investigating Alignment Healthcare, Inc. (ALHC) and Encourages Investors Who Suffered Losses to Contact the Firmnewsfilecorp.com
Jul-31-26
Jul-31-2604:25PM
Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Continues Following Whistleblower Lawsuit Of Financial Manipulationglobenewswire.com
11:05AM
ALHC INVESTORS WITH LOSSES: Contact Block & Leviton About Alignment Healthcare Securities Fraud Investigationnewsfilecorp.com
11:00AM
Kaplan Fox Reminds Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors of Potential Securities Law Violationsglobenewswire.com
Jul-30-26
Jul-30-2609:13PM
Alignment Healthcare, Inc. (ALHC) Q2 2026 Earnings Call Transcriptseekingalpha.com
07:31PM
Compared to Estimates, Alignment Healthcare (ALHC) Q2 Earnings: A Look at Key Metricszacks.com
06:26PM
Alignment Healthcare (ALHC) Beats Q2 Earnings and Revenue Estimateszacks.com
Company

Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue4,5783,9492,7041,8241,4341,168959757
Cost of Goods Sold Incl. D&A3,9393,4602,4071,6231,2501,039793661
Gross Profit24948929720118412916696
Selling, General and Administrative Excl. Other2520371307296291156110
Research and Development
00000000
Other Operating Expense260474272217161515
Operating Income5615-102-128-129-178-5-29
Interest Expense1616242118171715
Unusual Expense
————————
Non-Operating Income (Expense)00-31-20-10
Net Income Before Taxes39-1-128-148-149-195-23-45
Income Taxes
-20000000
Consolidated Net Income41-1-128-148-150-195-23-45
Net Income From Continuing Operations-7-1-128-148-150-195-23-45
Net Income41-1-128-148-150-195-23-45
EPS (Recurring)0.19-0.00-0.67-0.79-0.83-1.14-0.12-0.29
EPS (Basic, Before Extraordinaries)0.19-0.00-0.67-0.79-0.83-1.14-0.12-0.29
EPS (Diluted)0.19-0.00-0.67-0.79-0.83-1.14-0.12-0.29
EBITDA8745-77-105-114-1629-13
Other After Tax Adjustments
————————
Stock Option Compensation Expense
————————
Price To Earnings Ratio
71.16———————
Price To Sales Ratio0.610.990.790.881.482.07——
Gross Margin5.4412.3810.9811.0212.8311.0417.3112.68
Operating Margin1.220.38-3.77-7.02-9.00-15.24-0.52-3.83
Net Margin0.90-0.03-4.73-8.11-10.46-16.70-2.40-5.94
Shares Outstanding206198191186181172187152
Market Capitalization2,7853,9112,1491,6012,1292,418——
Operating Lease Expense
————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$26.50$22.30$18.10$13.90$9.70● Close Price0.00M161.25M322.49M483.74M644.99MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Maroney Dawn ChristinePresidentJul 15 '26Sale20.83177,0683,687,990922,313Jul 16
Maroney Dawn ChristinePresidentJul 15 '26Option Exercise9.06152,0681,377,7361,099,381Jul 16
KAO JOHN EChief Executive OfficerJul 10 '26Sale19.86298,0005,919,3611,088,766Jul 14
KONOWIECKI JOSEPH SEVP, Corporate AffairsJul 01 '26Sale24.0025,000600,0001,103,816Jul 01
KONOWIECKI JOSEPH SEVP, Corporate AffairsJun 26 '26Sale23.0025,000575,0001,128,816Jun 26
KONOWIECKI JOSEPH SEVP, Corporate AffairsJun 18 '26Sale22.0025,000550,0001,153,816Jun 18
Maroney Dawn ChristinePresidentJun 15 '26Sale19.5530,000586,425947,313Jun 15
Kim HyongChief Medical OfficerJun 12 '26Sale19.8635,951713,947331,750Jun 15
KONOWIECKI JOSEPH SEVP, Corporate AffairsJun 11 '26Sale21.0025,000525,0001,178,816Jun 12
KAO JOHN EChief Executive OfficerJun 10 '26Sale20.36298,0006,066,6211,386,766Jun 12
Kent Mark D.President - MSOJun 02 '26Buy13.3114,848197,62714,848Jun 02
Maroney Dawn ChristinePresidentMay 15 '26Sale16.0930,000482,565998,813May 19
KAO JOHN EChief Executive OfficerMay 11 '26Sale16.89298,0005,032,8501,508,641May 13
Maroney Dawn ChristinePresidentApr 15 '26Sale20.8730,000626,1991,028,813Apr 15
KAO JOHN EChief Executive OfficerApr 13 '26Sale20.8082,2991,711,6551,806,641Apr 13
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.